Oxycodone Terminated Phase N/A Trials for Chronic Myeloproliferative Disorders / Myelodysplastic Syndromes / Precancerous Conditions / Unspecified Adult Solid Tumor, Protocol Specific / Myelodysplastic/Myeloproliferative Neoplasms / Brain and Central Nervous System Tumors / Leukemias / Multiple Myeloma and Plasma Cell Neoplasm / Pain / Lymphoproliferative Disorders / Malignant Lymphomas Supportive Care

Indications	Status	Purpose	Phase
DBCOND0028462 (Chronic Myeloproliferative Disorders) DBCOND0027951 (Myelodysplastic Syndromes) DBCOND0029931 (Precancerous Conditions) DBCOND0028453 (Unspecified Adult Solid Tumor, Protocol Specific) DBCOND0028459 (Myelodysplastic/Myeloproliferative Neoplasms) DBCOND0028448 (Brain and Central Nervous System Tumors) DBCOND0035632 (Leukemias) DBCOND0028463 (Multiple Myeloma and Plasma Cell Neoplasm) DBCOND0012160 (Pain) DBCOND0028307 (Lymphoproliferative Disorders) DBCOND0046362 (Malignant Lymphomas)	Terminated	Supportive Care	Not Available

clinicaltrials.gov Identifier	Title	Drugs
NCT00726830	Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer	Morphine (DB00295) Methadone (DB00333) Oxycodone (DB00497)